
Overview
Genomic insights powered by QIAseq
QIAseq solutions are based on the following innovations to minimize bias and maximize genome coverage, uniformity and precision.
Amplicon sequencing
Outstanding sequencing metrics
Uniformity: Standard panels typically achieve uniformity of 99.5% at 0.2x of mean coverage and 96% at 0.5x of mean coverage.
Sensitivity: Gain higher confidence in calling low-frequency DNA variants. Standard panels can obtain over 90% sensitivity for 1% NA12878 SNP and indel on A typical coding region with false positives of less than 15 per megabase region.
More multiplexing: Products from other suppliers offer 96 sample multiplexing. QIAseq does not stop there: 384 samples can be multiplexed using indices specific to QIAseq.
Featured success story
QIAseq custom panels drive new insights into pancreatic cancer
Performing NGS in oncology research and looking to maximize coverage and access the most difficult regions of the genome? Then our QIAseq NGS panels may be just the tool you need to achieve impactful insights! A recent longitudinal case-control study on the risk of pancreatic cancer – led by Dr. Fergus Couch from the Mayo Clinic – illustrated the efficacy of our QIAseq Targeted DNA Panels in ensuring 99.7% coverage of target regions. Interested in applying the unique benefits of our QIAseq Targeted DNA Custom Panels your own research? Have a look at the details of the Mayo Clinic study for inspiration!
Reduce sample mix-up and maximize sequencing throughput
Whole exome sequencing
Sample to disease insights in record time
One optimized exome sequencing pipeline with reduced turnaround times to get you from sample to standardized variant classification and interpretation.
Whole genome sequencing
Single-cell DNA-seq
Metagenomics
Webinar highlights
Enterprise Genomics Solutions
Combine unparalleled expertise and support with our high-performance QIAseq technologies
Be part of the genomic revolution! Partner with QIAGEN to benefit from >20 years of experience in Sample to Insight solutions. From panel design to analysis and beyond – our Enterprise Genomic Solutions simplify biomarker discovery to propel your research forward.